Ascendis Pharma A/SASNDNASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank100
3Y CAGR+138.2%
5Y CAGR+150.9%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+138.2%/yr
vs +48.3%/yr prior
5Y CAGR
+150.9%/yr
Recent deceleration
Acceleration
+89.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
99.5x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$691.71M+90.2%
2024$363.64M+36.3%
2023$266.72M+421.2%
2022$51.17M+557.9%
2021$7.78M+11.9%
2020$6.95M-48.0%
2019$13.38M+26.4%
2018$10.58M+591.6%
2017$1.53M-66.8%
2016$4.61M-